Skip to main content

Table 1 Clinical data of 21 patients with pulmonary pathology selected from 525 subjects with suspicion of paraneoplastic neurological syndromes.

From: Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome

Patient Age Gender Antibody NPS Pulmonary disease
J.F. 56 Male Negative Motor neuron disease Small-cell lung cancer
J.W. 52 Male Anti-Ri, anti-Yo Neuropathy Chronic obstructive pulmonary disease
B.K. 54 Female Negative Neuropathy Non-small-cell lung cancer, brain metastases
K.K. 55 Female Negative Neuropathy Non-small-cell lung cancer
S.P. 75 Male Anti-Hu Limbic encephalitis Small-cell lung cancer
E.S. 42 Female Negative Pyramidal syndrome Non-small-cell lung cancer
A.S. 41 Male Negative Pyramidal syndrome Pulmonary sarcoidosis
S.K. 31 Female Anti-myelin Cerebellar syndrome Bronchial asthma
W.J. 57 Female Anti-MAG Neuropathy Bronchial asthma
A.S. 51 Female Negative Polymyositis Non-small-cell lung cancer, ovarian cancer
K.G. 58 Female Anti-MAG Neuropathy Small-cell lung cancer
H.R. 47 Female Anti-Hu Pyramidal syndrome Small-cell lung cancer
K.L. 60 Female Anti-Ri Neuropathy Breast cancer, pulmonary metastases
I.N. 53 Female Negative Brachial plexopathy Pulmonary metastases
T.Z. 70 Female Negative Myopathy Chronic obstructive pulmonary disease
A.S. 41 Male Negative Pyramidal syndrome Pulmonary sarcoidosis
W.J. 57 Female Anti-MAG Neuropathy Bronchial asthma
I.B. 38 Female Anti-MAG Myasthenia gravis Bronchial asthma
F.C. 68 Male Anti-MAG Neuropathy Small-cell lung cancer
A.K. 52 Female Negative Neuropathy Small-cell lung cancer, brain metastases
A.B. 69 Female Anti-amphiphysin Limbic encephalitis, paraneoplastic cerebellar degeneration. Non-small-cell lung cancer